Results 101 to 110 of about 1,619,240 (186)

Comparative Analysis of Potential Side Effects of Targeted Oral Hypoglycemic Agents Using Spontaneous Adverse Event Reports and Social Media Data. [PDF]

Pharmacoepidemiol Drug Saf
Oh SH, Park DY, Song YK.
europepmc   +1 more source

Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes： A Network Meta-Analysis. [PDF]

Front Endocrinol (Lausanne), 2021
Lian J, Fu J.
europepmc   +1 more source

Continuity and Completeness of Electronic Health Record Data for Patients Treated With Oral Hypoglycemic Agents: Findings From Healthcare Delivery Systems in Taiwan. [PDF]

Front Pharmacol, 2022
Hsu CN, Huang K, Lin FJ, Ou HT, Huang LY, Kuo HC, Wang CC, Toh S.   +7 more
europepmc   +1 more source

Hypoglycemic agents and contrast-induced acute kidney injury in type 2 diabetes: A retrospective cohort study of patients undergoing coronary angiography or percutaneous coronary intervention. [PDF]

Sci Prog
Guo D, Du X, Zhang T, Liu R, Ma M.
europepmc   +1 more source

Trends in HbA_1c thresholds for initiation of hypoglycemic agents: Impact of changed recommendations for older and frail patients. [PDF]

Pharmacoepidemiol Drug Saf, 2021
Ambrož M, de Vries ST, Hoogenberg K, Denig P.   +3 more
europepmc   +1 more source

Comparative Effectiveness of Insulin Versus Oral Hypoglycemic Agents in Diabetic Patients With Acute Stroke: A Retrospective Cross-Sectional Analysis of Treatment Outcomes and Influencing Factors. [PDF]

Health Sci Rep
Salehi M, Maghbooli M, Bagheri M, Sany SNT, Arfaei M.   +4 more
europepmc   +1 more source

The concentration-dependent protective effects by new generation hypoglycemic agents on delirium, depression, dementia and coma: evidence from a network meta-analysis. [PDF]

J R Soc Med
Tseng PT, Zeng BY, Hsu CW, Suen MW, Hung CM, Carvalho AF, Stubbs B, Chen YW, Chen TY, Lei WT, Lin PY, Chen JJ, Su KP, Wang HY, Zeng BS, Shiue YL, Liang CS.   +16 more
europepmc   +1 more source

Effects of Short-Term Intensive Insulin Therapy Combined With Oral Hypoglycemic Agents for Inducing Remission in Newly Diagnosed Type 2 Diabetes Mellitus: A Randomized Clinical Trial. [PDF]

J Diabetes
Ke W, Liu L, Zhang P, Yan L, Zhang Q, Zhang F, Xu X, Liu J, Xu L, Wan X, Li H, Cao X, Xiao H, Putman MS, Li Y.   +14 more
europepmc   +1 more source

The Efficacy and Safety of Hypoglycemic Agents in the Middle-Aged and Elderly Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis. [PDF]

Iran J Public Health
Huang J, Qiu H, Meng K.
europepmc   +1 more source

Treatment intensity-dependent association between the number of oral hypoglycemic agents and insulin use and lung cancer risk in patients with type 2 diabetes. [PDF]

Transl Lung Cancer Res
Chung C, Lee KN, Han K, Shin DW, Lee SW.
europepmc   +1 more source